Medicare – Medxy AI

Telemedicine After the Pandemic: Who Benefits, What Changed, and What Comes Next

By MedXY 05/18/2026

Telemedicine is no longer an emergency workaround. New policy guidance shows how virtual care can improve access, but only if payment, safety, equity, and prescribing rules evolve carefully.

Cardiology news

Sex-Based Patterns and Trends in Transcatheter Aortic Valve Implantation

By MedXY 05/10/2026

A 10-year Medicare study reveals women face higher immediate risks during TAVI procedures but demonstrate better long-term survival than men, despite declining representation in treatment.

news Oncology Public Health

Medicare’s Oncology Care Model Did Not Increase Systemic Therapy Starts and Was Linked to Lower Use in Poor-Prognosis Cancer

By MedXY 05/05/2026

A matched difference-in-differences study found that the Oncology Care Model did not increase systemic therapy initiation overall and was associated with lower treatment initiation and lower spending in poor-prognosis cancers.

Cardiology news Public Health

ATTR-CM Is Often Diagnosed Years After Heart Failure in Medicare Patients

By MedXY 04/30/2026

In Medicare beneficiaries, ATTR-CM was diagnosed a median 494 days after heart failure and 840 days after loop diuretic initiation, with delays more common in women and patients with several common comorbidities.

news Public Health Urology

Maryland’s Global Budget Revenue Model Was Linked to Better Cancer Surgery Outcomes and Lower Medicare Spending

By MedXY 04/20/2026

In a large Medicare study, hospitals under Maryland’s global budget model showed modest but significant improvements in cancer surgery outcomes, driven by fewer complications and shorter stays, with lower inpatient spending.

Neurology news Public Health

Money Talks: How Pharmaceutical Industry Payments Influence MS Doctors to Prescribe Costlier Brand-Name Drugs Over Generics

By MedXY 04/08/2026

A new study reveals that neurologists receiving $1,000 or more from drug manufacturers were over 4 times more likely to prescribe expensive brand-name MS medications when generics were available, driving up costs for patients and the healthcare system.

Cardiology General Surgery news

Volume Matters: New Study Defines Minimum Annual Caseload for Safer Fenestrated and Branched Aortic Repair

By MedXY 04/02/2026

Researchers identify critical hospital and surgeon volume thresholds for fenestrated/branched endovascular aortic repair (F/BEVAR). Patients treated at low-volume centers face up to 51% higher 30-day mortality, with inflection points at 9 hospital cases and 7 surgeon cases annually.

Cardiology Neurology news

Rethinking First-Line Anticoagulation in Older Adults: Real-World Evidence Challenges Conventional AFib Management

By MedXY 01/07/2026

A large-scale study of 144,969 Medicare beneficiaries reveals that initial anticoagulant prescriptions for atrial fibrillation may not reduce ischemic stroke risk in patients over 66, while significantly increasing major bleeding hazards, suggesting a need for more nuanced, individualized clinical decision-making.

Hematology-Oncology news Oncology

Clinical Benefit—not Billing Margin—Drives Oncologists’ Treatment Choices in Medicare Cohort

By MedXY 11/22/2025

In a population-based Medicare cohort, oncologists preferentially selected higher-clinical-benefit cancer treatments; provider billing margin was not associated with treatment choice, suggesting price or payment reforms that change margins may not meaningfully alter treatment patterns.